Hansa Biopharma AB (publ)
Hansa Biopharma AB (publ) (HNSBF) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
hnsbf · market cap & enterprise value · FMP · as of Jun 5, 2026
Core market cap & key metrics
As of Jun 5, 2026, Hansa Biopharma AB (publ) (HNSBF) has a market cap — also referred to as its net worth or valuation — of $245,799,865, making it one of the top most valuable companies globally. Market Cap = $2.90 × shares outstanding.
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Hansa Biopharma AB (publ) (HNSBF) has a market cap — also referred to as its net worth or valuation — of $245,799,865 as of Jun 5, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Hansa Biopharma AB (publ) reached its all-time high market cap of $0 on —. Comparing the Hansa Biopharma AB (publ) market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Hansa Biopharma AB (publ) net worth vs peers and ask how Hansa Biopharma AB (publ) valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
HNSBF market cap · 6 questionsHansa Biopharma AB (publ)'s net worth — measured as market capitalization — is $245,799,865 as of Jun 5, 2026. It ranks #0 globally. Market Cap = $$2.90 (price) × shares outstanding.